US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

249.65

-16.1400-6.07%

Pre-market: 254.765.11+2.05%06:21 EDT

Volume:444.68K

Turnover:115.14M

Market Cap:567.83M

PE:- -

High:271.79

Open:261.76

Low:248.93

Close:265.79

52wk High:341.93

52wk Low:95.98

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.37

T/O Rate:19.55%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

FDA import ban puts Sheng Nuo Biotec's US business on red alert

Health Care Roundup: Market Talk

Sonic Healthcare Issues New Performance Rights Under Employee Incentive Scheme

Sonic Healthcare Options Lapse Simplifies Capital Structure

Global Multi-Cancer Early Screening Clears FDA Expert Panel, BGI Genomics' Early Screening Business Approaches Next Product Realization Window

Kenedix Office REIT Accelerates Asset Reshuffle with Healthcare Exit and New Acquisitions

KDX Realty Investment Reshapes Portfolio with Office, Residential and Hotel Buys, Healthcare Sale

Kringle Pharma Submits IND Application for Spinal Cord Injury Drug to U.S. FDA; Shares Jump 7%

MT Newswires Live

FDA Advisory Panel Endorses Blood Test Designed to Detect Dozens of Cancer Types, Signaling a Potential New Era for AI-Powered Screening

Malaysia Healthcare Sector Likely Supported by Structural Demand

3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst

Nexsen Refines StrepSure After Interim Trial, Nudging Back U.S. FDA Timeline

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

Ramsay Health Care Lifts CEO Maximum LTI Opportunity

MT Newswires Live

HealthCo Healthcare and Wellness REIT Says Perth Hospital Completes Transition to New Operator

MT Newswires Live

Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval

Ramsay Health Care refreshes board with retirement of long-serving director and appointment of Dr Tracey Batten

FDA panel votes in favor of Grail’s Galleri benefits outweighing risks

Ramsay boosts CEO long-term incentive while holding base pay steady

FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":249.65,"timestamp":1790884800000,"preClose":265.79,"halted":0,"volume":444675,"hourTrading":{"tag":"盘前","latestPrice":254.76,"preClose":249.65,"latestTime":"06:21 EDT","volume":643,"amount":163302.80645,"timestamp":1790936483993,"change":5.11,"changeRate":0.020469,"amplitude":0.010054},"delay":0,"changeRate":-0.060724632228451085,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Pre-Mkt","change":-16.14,"latestTime":"10-02 06:26:26 EDT","open":261.76,"high":271.79,"low":248.93,"amount":115144402.4115,"amplitude":0.086008,"askPrice":267.18,"askSize":10,"bidPrice":252.04,"bidSize":300,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790947800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":265.086,"aum":616188302.35,"dividendRate":0.00362,"bidAskSpread":0.003421,"preHourTrading":{"tag":"盘前","latestPrice":254.76,"preClose":249.65,"latestTime":"06:21 EDT","volume":643,"amount":163302.80645,"timestamp":1790936483993,"change":5.11,"changeRate":0.020469,"amplitude":0.010054},"postHourTrading":{"tag":"盘后","latestPrice":251.75,"preClose":249.65,"latestTime":"19:59 EDT","volume":7054,"amount":1775509.5491,"timestamp":1790899181648,"change":2.1,"changeRate":0.008412,"amplitude":0.011416},"volumeRatio":1.3688031629226816,"impliedVol":0.9424,"impliedVolPercentile":0.608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.3688031629226816,"shares":2274486,"dividePrice":0.9037,"high":271.79,"amplitude":0.086008,"preClose":265.79,"low":248.93,"week52Low":95.98,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":249.65,"committee":0.935484,"eps":0,"divideRate":0.00362,"volume":444675,"delay":0,"ttmEps":0,"open":261.76,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.32,"twentyDayClose":311.81,"sixtyDayClose":317.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193027650","title":"FDA import ban puts Sheng Nuo Biotec's US business on red alert","url":"https://stock-news.laohu8.com/highlight/detail?id=1193027650","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193027650?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:40","pubTimestamp":1790239239,"startTime":"0","endTime":"0","summary":"After its subsidiary Sheng Nuo Pharmaceutical underwent an on-site FDA inspection, peptide CDMO company Chengdu Sheng Nuo Biotec Co.,Ltd. (688117) received a Form 483 observation list and was...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688117","LABU","BK4588","BK4585","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669042468","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669042468","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669042468?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:20","pubTimestamp":1790238000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0721 GMT - Hikma Pharmaceuticals' new chief financial officer is","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669826468","title":"Sonic Healthcare Issues New Performance Rights Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2669826468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669826468?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:48","pubTimestamp":1790236106,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Sonic Healthcare Limited ( ($AU:SHL) ). Sonic Healthcare Limited has notified the market of the issue of 72,014...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-issues-new-performance-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-issues-new-performance-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669468817","title":"Sonic Healthcare Options Lapse Simplifies Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669468817","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669468817?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:34","pubTimestamp":1790235274,"startTime":"0","endTime":"0","summary":"An announcement from Sonic Healthcare Limited ( ($AU:SHL) ) is now available. Sonic Healthcare Limited has notified the market of the cessation of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-options-lapse-simplifies-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-options-lapse-simplifies-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","XLV","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155851563","title":"Global Multi-Cancer Early Screening Clears FDA Expert Panel, BGI Genomics' Early Screening Business Approaches Next Product Realization Window","url":"https://stock-news.laohu8.com/highlight/detail?id=1155851563","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155851563?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:21","pubTimestamp":1790234511,"startTime":"0","endTime":"0","summary":"On September 23, Eastern Time, the Molecular and Clinical Genetics Panel, a subdivision of the FDA's Medical Devices Advisory Committee, convened a public meeting to review GRAIL's Premarket Approval...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300676","BK0042","BK0197","BK4588","BK0221","BK4585","BK0196","LABU","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669034452","title":"Kenedix Office REIT Accelerates Asset Reshuffle with Healthcare Exit and New Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669034452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669034452?lang=en_us&edition=fundamental","pubTime":"2026-09-24 14:55","pubTimestamp":1790232939,"startTime":"0","endTime":"0","summary":"Kenedix Office Investment Corporation ( ($JP:8972) ) has provided an announcement. Kenedix Office Investment Corporation announced a series of acqu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kenedix-office-reit-accelerates-asset-reshuffle-with-healthcare-exit-and-new-acquisitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kenedix-office-reit-accelerates-asset-reshuffle-with-healthcare-exit-and-new-acquisitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCF","IQRA","LU0128526141.USD","BPRE","LU0029874061.USD","BK4585","HCSG","XBI","RJMG","YLDW","IVRA","BK4137","MDIV","RNTY","XLV","BK4588","LABU","BK4581","DFRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669452012","title":"KDX Realty Investment Reshapes Portfolio with Office, Residential and Hotel Buys, Healthcare Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2669452012","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669452012?lang=en_us&edition=fundamental","pubTime":"2026-09-24 14:55","pubTimestamp":1790232928,"startTime":"0","endTime":"0","summary":"Kenedix Office Investment Corporation ( ($JP:8972) ) just unveiled an update. KDX Realty Investment Corporation will acquire one office building in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kdx-realty-investment-reshapes-portfolio-with-office-residential-and-hotel-buys-healthcare-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kdx-realty-investment-reshapes-portfolio-with-office-residential-and-hotel-buys-healthcare-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","LU0128526141.USD","BK4137","XBI","XLV","HCSG","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669456062","title":"Kringle Pharma Submits IND Application for Spinal Cord Injury Drug to U.S. FDA; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669456062","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669456062?lang=en_us&edition=fundamental","pubTime":"2026-09-24 12:21","pubTimestamp":1790223665,"startTime":"0","endTime":"0","summary":"Kringle Pharma  submitted an Investigational New Drug  application to the U.S. Food and Drug Administration  to initiate a phase three clinical trial in the U.S. for acute spinal cord injury drug oremepermin alfa.The proprietary recombinant human HGF therapeutic, Oremepermin alfa, completed phase one/two and phase three trials in Japan for acute spinal cord injury, the late-stage clinical biopharmaceutical company said in a Thursday filing with the Japan bourse.The company is carrying out an additional Phase 3 trial to support a future regulatory submission, while the drug has secured orphan drug designation for acute SCI in Japan, the U.S. and Europe, it said.Shares of Kringle Pharma added nearly 7% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","IND.AU","BK7095","BK4588","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165545226","title":"FDA Advisory Panel Endorses Blood Test Designed to Detect Dozens of Cancer Types, Signaling a Potential New Era for AI-Powered Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=1165545226","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165545226?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:26","pubTimestamp":1790216790,"startTime":"0","endTime":"0","summary":"On September 23, 2026, the field of multi-cancer early detection reached a significant milestone. The U.S. FDA's Molecular and Clinical Genetics Panel reviewed GRAIL's Galleri multi-cancer early...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","QTOC","CHAT","ARTY","BK4585","BK4588","AIPO","LABU","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669453675","title":"Malaysia Healthcare Sector Likely Supported by Structural Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669453675","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669453675?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:20","pubTimestamp":1790216400,"startTime":"0","endTime":"0","summary":"0220 GMT - Malaysian healthcare sector could remain supported by the rising prevalence of non-communicable diseases, an ageing population, and increasing health awareness, CIMB Securities analyst Chun Sung Oong says in a note. He pegs IHH Healthcare as his new top pick, citing its stronger earnings visibility. IHH's business is expected to benefit from patients shifting to private hospitals amid high occupancy at public hospitals. In India, Gleneagles India's profitability is expected to improve as it works more closely with Fortis Healthcare. The potential IPO of AsiaOne Healthcare could renew investor interest in Malaysia's healthcare sector, as the listing could support higher valuations, he adds. CIMB maintains an overweight rating on the Malaysian healthcare sector.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","HCSG","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430290","title":"3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430290","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669430290?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:13","pubTimestamp":1790212391,"startTime":"0","endTime":"0","summary":"TipRanks’ ETF AI Analyst has an Outperform rating on the Schwab U.S. Dividend Equity ETF ($SCHD), Health Care Select Sector SPDR Fund ($XLV), and V...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-etfs-that-could-deliver-11-returns-according-to-the-ai-analyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-etfs-that-could-deliver-11-returns-according-to-the-ai-analyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTHR","AGIX","AIPO","BK4585","LABU","FDN","XLV","BK4581","QTOC","BK4550","SCHD","XBI","CHAT","ARTY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669374874","title":"Nexsen Refines StrepSure After Interim Trial, Nudging Back U.S. FDA Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2669374874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669374874?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:37","pubTimestamp":1790210252,"startTime":"0","endTime":"0","summary":"Nexsen Limited ( ($AU:NXN) ) has issued an update. Nexsen Limited has halted enrollment in its Melbourne clinical study of StrepSure after a planne...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexsen-refines-strepsure-after-interim-trial-nudging-back-u-s-fda-timeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexsen-refines-strepsure-after-interim-trial-nudging-back-u-s-fda-timeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","BK4139","LABU","BK4588","NVIB","LFSC","MRNX","BK4585","XLVX","MEDI","GNMX","BBP","IBB","GDOC","FRTY","IYH","TBXU","IEIH","IDNA","RSPH","PSCH","PINK","SYNB","MESO","TECB","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669043280","title":"Ramsay Health Care Lifts CEO Maximum LTI Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043280","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043280?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:51","pubTimestamp":1790207462,"startTime":"0","endTime":"0","summary":"Ramsay Health Care  has raised Group Chief Executive Natalie Davis' maximum long-term incentive  opportunity to 170% of fixed annual remuneration  from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RHC.AU","FAR.AU","BK4585","XLV","BK4588","LABU","BK4581","BK7113","BK7142","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669043402","title":"HealthCo Healthcare and Wellness REIT Says Perth Hospital Completes Transition to New Operator","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043402","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043402?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:44","pubTimestamp":1790207062,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT  said the Mount Private Hospital in Perth completed a transition of operations to Bethesda Health Care from Healthscope, according to a Thursday filing with the Australian bourse.The new long-term lease with Bethesda is guaranteed by the Western Australia state government, per the filing.The hospital is fully owned by the Unlisted Healthcare Fund, in which HealthCo Healthcare has a 49.6% interest.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRT.SI","CLR.SI","CFA.SI","RNTY","LU0128526141.USD","LU0029874061.USD","BK6142","LABU","HCSG","SRU.SI","HCW.AU","BK7156","BK4581","IQRA","RJMG","BK4585","BK7149","YLDW","XBI","BPRE","PSCF","GLS.SI","BK4588","IVRA","BK4137","XLV","DFRA","8C8U.SI","JJJ.SI","MDIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431216","title":"Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431216","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431216?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:35","pubTimestamp":1790202900,"startTime":"0","endTime":"0","summary":"Grail Inc. received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test.The cancer-detection company said the FDA's medical devices advisory committee voted 7-2, with one abstention, to greenlight a premarket approval application for Galleri.The FDA isn't bound to the committee's recommendation, but it takes them into consideration when making the final regulatory decision. The FDA is expected to make its final ruling on Galleri's premarket approval in the coming months.In three separate votes, the 10 voting members of the committee considered Galleri's safety, effectiveness and overall benefit-risk profile for screening and early detection of multiple types of cancer in adults aged 50 and older.The Galleri test is designed to detect cancer-specific methylation patterns shared by many types of cancer before symptoms appear, including cancers that don't have recommended screening today.When a cancer si","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABU","BK4588","GRAL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669311884","title":"Ramsay Health Care refreshes board with retirement of long-serving director and appointment of Dr Tracey Batten","url":"https://stock-news.laohu8.com/highlight/detail?id=2669311884","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669311884?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:12","pubTimestamp":1790201539,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) just unveiled an update. Ramsay Health Care announced that long-serving Non-Executive Director Michael Siddle will...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-refreshes-board-with-retirement-of-long-serving-director-and-appointment-of-dr-tracey-batten?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-refreshes-board-with-retirement-of-long-serving-director-and-appointment-of-dr-tracey-batten?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","BK4581","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669319284","title":"FDA panel votes in favor of Grail’s Galleri benefits outweighing risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669319284","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669319284?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:10","pubTimestamp":1790201424,"startTime":"0","endTime":"0","summary":"The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee voted to recommend approval for Grail’s (GRAL) Galleri, a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-panel-votes-in-favor-of-grails-galleri-benefits-outweighing-risks-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-panel-votes-in-favor-of-grails-galleri-benefits-outweighing-risks-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431944","title":"Ramsay boosts CEO long-term incentive while holding base pay steady","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431944","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431944?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:03","pubTimestamp":1790200986,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has provided an announcement. Ramsay Health Care has updated the remuneration structure for Group CEO and Managing...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-boosts-ceo-long-term-incentive-while-holding-base-pay-steady?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-boosts-ceo-long-term-incentive-while-holding-base-pay-steady?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","LABU","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431891","title":"FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431891","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431891?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:30","pubTimestamp":1790199013,"startTime":"0","endTime":"0","summary":"17:26 EDT FDA panel says Grail’s (GRAL) cancer detection blood test is safe, Bloomberg says Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-panel-says-grails-cancer-detection-blood-test-is-safe-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-panel-says-grails-cancer-detection-blood-test-is-safe-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585","GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":13,"totalSize":387,"code":"91000000","status":"200"}]}}